MedTrace Logo

Use of Heart Rate Variability (HRV) Biofeedback for Cancer Survivors

NCT03692624 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2020-03-06

No results posted yet for this study

Summary

Heart rate variability biofeedback (HRV-B) is a complementary, non-pharmacologic therapy that is being tested to see if it can help cancer survivors reduce their symptoms of pain, stress, insomnia, fatigue, or depression. HRV-B is an interactive procedure in which participants relax and breathe regularly while watching the a computer screen. The computer screen provides feedback that helps people increase their heart rate variability.

Conditions

Interventions

BEHAVIORAL

Biofeedback

Heart Rate Variability Biofeedback

Sponsors & Collaborators

  • University of South Carolina

    collaborator OTHER

  • Prisma Health-Upstate

    lead OTHER

Principal Investigators

  • Mark A O'Rourke, MD · Prisma Health-Upstate

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-10
Primary Completion
2017-04-19
Completion
2020-02-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03692624 on ClinicalTrials.gov